BioNxt Solutions Inc. (CVE:BNXT)

BRIEF

published on 11/20/2025 at 09:10, 4 months 2 days ago

BioNxt obtient un brevet eurasien pour sa plateforme de cladribine sublinguale

Marché Mondial Maladies Auto-immunes Solutions BioNxt Cladribine Sublinguale Brevet Accordé
BRIEF

published on 11/20/2025 at 09:10, 4 months 2 days ago

BioNxt Receives Eurasian Patent for Sublingual Cladribine Platform

Global Market Autoimmune Diseases Patent Grant BioNxt Solutions Sublingual Cladribine
PRESS RELEASE

published on 11/20/2025 at 09:05, 4 months 2 days ago

BioNxt Secures Final Patent Grant from the Eurasian Patent Organization for Sublingual Cladribine Platform
BioNxt Solutions Inc. receives Eurasian Patent No. 051510 for sublingual anticancer drug delivery system, a key milestone in global IP strategy. Expansion to EU and US markets in progress

BioNxt Solutions Inc. Sublingual Delivery Eurasian Patent Pharmaceutical Markets Global IP Strategy
BRIEF

published on 11/04/2025 at 09:10, 4 months 18 days ago

BioNxt Receives European Patent Notification for Cladribine Thin-Film

Multiple Sclerosis Oral Therapies Cladribine European Patent BioNxt
BRIEF

published on 11/04/2025 at 09:10, 4 months 18 days ago

BioNxt reçoit une notification de brevet européen pour son film mince de cladribine

Sclérose En Plaques Thérapies Orales Cladribine Brevet Européen BioNxt
PRESS RELEASE

published on 11/04/2025 at 09:05, 4 months 18 days ago

BioNxt Reports "Intention to Grant" Patent Notification from the European Patent Office for Its Oral Cladribine Sublingual Thin-Film as the Multiple Sclerosis Market Shifts Toward Patient-Friendly Therapies
BioNxt Solutions Inc. receives 'Intention to Grant' notification from European Patent Office for sublingual cladribine thin-film formulation for MS treatment, securing extensive IP protection across Europe and Eurasia

BioNxt Solutions Inc. European Patent Office MS Treatment Sublingual Thin-Film Global Patent Coverage
BRIEF

published on 10/30/2025 at 08:10, 4 months 23 days ago

BioNxt Solutions Inc. Advances Patent for Cancer Drug Delivery

Multiple Sclerosis Drug Delivery BioNxt Solutions Eurasian Patent Patent Strategy
BRIEF

published on 10/30/2025 at 08:10, 4 months 23 days ago

BioNxt Solutions Inc. fait progresser un brevet pour l'administration de médicaments anticancéreux

Sclérose En Plaques Solutions BioNxt Administration De Médicaments Brevet Eurasien Stratégie En Matière De Brevets
PRESS RELEASE

published on 10/30/2025 at 08:05, 4 months 23 days ago

BioNxt Reports "Readiness to Grant" Patent Notification from the Eurasian Patent Organization
BioNxt Solutions Inc. receives "Readiness to Grant" notification from EAPO for comprehensive patent application on sublingual delivery of anticancer drugs for autoimmune neurodegenerative diseases, including lead product BNT23001 for MS treatment. Patent protection strengthens commercialization strategy

BioNxt Solutions Inc. Patent Application Sublingual Drug Delivery Anticancer Drugs EAPO
BRIEF

published on 10/21/2025 at 09:10, 5 months 1 day ago

BioNxt Initiates Sublingual Cladribine Study for MS Treatment Optimization

Multiple Sclerosis Bioavailability Drug Delivery Bioequivalence Study Sublingual Cladribine

Published on 03/20/2026 at 23:00, 1 day 19 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 1 day 21 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 1 day 21 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 5 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 6 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

Published on 03/22/2026 at 18:22, 11 minutes ago

Test news - please ignore EN
Published on 03/22/2026 at 12:23, 6 hours 10 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 19 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 21 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 21 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion

View all EQS

Published on 03/20/2026 at 19:00, 1 day 23 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 23 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 2 days ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News